Unicycive Therapeutics's total assets for Q2 2025 were $30.00M, an increase of 7.33% from the previous quarter. UNCY total liabilities were $13.57M for the fiscal quarter, a -18.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.